BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Parse Biosciences Launches Evercode™ Low Input Fixation Kits, Enabling Single Cell Sequencing with Minimal Starting Material

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Ever...

November 05, 2024 | News

Medidata Introduces Oncology and Vaccine Solutions to Streamline Phase II and III Trials with FDA-Aligned Patient-Centric Design

The new products combine Medidata's diverse technologies and experience from thousands of previous trials to streamline the management of Phase II an...

November 05, 2024 | News

Breast Cancer Drug Shows Promise for Treating Hereditary Hemorrhagic Telangiectasia, a Rare Vascular Disorder

A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic ble...

November 05, 2024 | News

Wasatch BioLabs and Oxford Nanopore Collaborate on Breakthrough Direct Whole Methylome Sequencing Product

Wasatch Biolabs (WBL), a disruptive R&D and high-throughput clinical laboratory, today announced a collaboration with Oxford Nanopore Technologies (ONT...

November 04, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Jubilant Radiopharma Partners with Simplified Imaging Solutions to Launch First Comprehensive Nuclear Medicine Solution in the U.S.

Jubilant Radiopharma, a business segment of Jubilant Pharmova Limited, with the second largest network of Radiopharmacies in the United States (U.S.) and S...

October 31, 2024 | News

Siemens Healthineers Expands Atellica Integrated Automation to Atellica CI Analyzer, Transforming Clinical Lab Operations

Siemens Healthineers is pleased to announce the expansion of its Atellica Integrated Automation solution to the Atellica CI Analyzer, bringing advanced aut...

October 31, 2024 | Product Spotlight

Australia's Telix Pharmaceuticals Partners with Subtle Medical for AI-Powered PET Imaging, Enhancing Illuccix® Efficiency and Patient Experience

Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...

October 31, 2024 | News

Complete Genomics Integrates DNBSEQ Platforms with NVIDIA Parabricks to Enhance Speed, Accuracy, and Affordability of Genomic Analysis

Complete Genomics announced an integration of its next-generation sequencing (NGS) DNBSEQ platforms* with NVIDIA Parabricks software for secondary analysis...

October 30, 2024 | News

I Peace, Inc. Introduces HLA-Homozygous iPSC Line to Boost Compatibility and Accessibility in Allogenic Cell Therapies

I Peace, Inc., a leading GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPS...

October 30, 2024 | News

Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | News

Innovent's Picankibart Shows Promising Results in Phase 2 Trial for Psoriasis Patients Unresponsive to Previous Biologics

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 29, 2024 | News

LakeShore Biopharma Gains NMPA Approval for Phase III Trial of Simplified Four-Dose Rabies Vaccine Regimen

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developin...

October 28, 2024 | News

Corvia Medical’s Atrial Shunt Demonstrates Long-Term Efficacy in Heart Failure Patients: Three-Year Trial Results Published

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced impressive three-year results from its REDUCE LAP-HF II ...

October 28, 2024 | News

Stay Connected